INTERMEDIATE AND PROCESS FOR PRODUCING OPTICALLY ACTIVE COMPOUND FROM THE INTERMEDIATE

Details for Australian Patent Application No. 2002359990 (hide)

Owner ONO PHARMACEUTICAL CO., LTD.

Inventors TATSUTA, Kuniaki

Pub. Number AU-A-2002359990

PCT Number PCT/JP02/13236

PCT Pub. Number WO2003/051852

Priority 2001-385621 19.12.01 JP

Filing date 18 December 2002

Wipo publication date 30 June 2003

International Classifications

C07D 263/26 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07M 007/00

C07C 051/06 Preparation of carboxylic acids or their salts, halides, or anhydrides - from carboxylic acid amides

C07C 053/128 Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen

C07C 057/03 Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms

C07C 057/18 Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 2001-385621 19.12.01 JP

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002359990

2 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002359991-E-COMMERCE PAYMENT SYSTEM FOR DIGITAL BROADCASTING AND THE METHOD THEREOF

2002359989-SPLINT COMBINED USE CAST ABSENCE FOR BONE FRACTURE FIXING